Indication
ATTR-CM
1 clinical trial
2 products
Product
AG10Clinical trial
A Phase 2, Randomized, Placebo-controlled, Dose-ranging Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AG10 in Patients With Symptomatic Transthyretin Amyloid CardiomyopathyStatus: Completed, Estimated PCD: 2018-10-05
Product
Placebo